Exeliom Biosciences
Phase 2At Exeliom Biosciences, we develop novel therapeutic approaches to unleashthe therapeutic potential of key players in the Microbiome - Host interactions to fightimmune-mediated diseases, starting with inflammatory bowel diseases
Founded
2016
Focus
BiologicsMicrobiome
About
At Exeliom Biosciences, we develop novel therapeutic approaches to unleashthe therapeutic potential of key players in the Microbiome - Host interactions to fightimmune-mediated diseases, starting with inflammatory bowel diseases
Funding History
2Total raised: $30.5M
Series A$25MSofinnova PartnersNov 15, 2023
Seed$5.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2016
LocationParis, France
StagePhase 2
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile